Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Capecitabine as Maintenance Therapy Versus Observation on Patients With Early Stage Triple Negative Breast Cancer

NCT07143097 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT07143097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07143097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Capecitabine as Maintenance Therapy Versus Observation on Patients With Early Stage Triple Negative Breast Cancer
Lead sponsor
Beni-Suef University
Phase
Phase 2
Overall status
Completed
Start date
November 1, 2021
Completion date
May 30, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple -negative breast cancer